Tag Archives: Alternatives to Antipsychotics

Summary of NICE’s Impact on Dementia Health and Care (NICE)

Posted on February 9, 2020 by Dementia and Elderly Care News

Summary A National Institute for Health and Care Excellence (NICE) marketing report gives an overview of progress in implementing NICE guidance across health and care. The main section headings comprise: Prevent or delay onset of dementia. Referral, diagnosis and care … Continue reading →

Systematic Review of Meaningful Activity for People With Dementia in Long-Term Care (Cochrane Database / NIHR Signal / PLoS Medicine)

Posted on March 29, 2018 by Dementia and Elderly Care News

Summary Mainstream opinion is nowadays in favour of providing personally-tailored meaningful activity for people with dementia in long-term care, as a means of improving mental wellbeing and quality of life, and / or reducing challenging behaviour without resort to antipsychotics. … Continue reading →

Posted in Commissioning, Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, NIHR, Non-Pharmacological Treatments, Person-Centred Care, Personalisation, Quick Insights, Systematic Reviews, UK, Universal Interest | Tagged Agitation, Agitation and Aggression, Alternatives to Antipsychotics, Alternatives to Medication for Agitation, Antipsychotic Prescribing in Care Homes, Behavioural and Psychological Symptoms of Dementia (BPSD), Best Practice in Care Homes, Broaden-and-Build Theory, Care Homes, Care Homes Wellbeing, Division of Psychiatry and Applied Psychology: University of Nottingham, Division of Psychiatry: University College London, Encouraging Independence and Social Interaction, Exeter University, Exeter University Medical School: Exeter University, Faculty of Health and Social Sciences: University of Hull, Faculty of Medicine: University of Freiburg, Germany, Helse Stavanger University Hospital (Norway), Improving Wellbeing and Health for People with Dementia (WHELD) Trial, Individualized Positive Psychosocial Intervention (IPPI), Individualized Positive Psychosocial Interventions, Individualized Social Activity Intervention (ISAI), Institute for Evidence in Medicine (for Cochrane Germany Foundation): University of Freiburg, Institute of Mental Health: University of Nottingham, Kings College London, London School of Economics, Maintaining Identity, Maintaining Independence, Managing Agitation, Managing Ongoing Physical and Mental Health Conditions, Meaningful Activity, Meaningful Activity and Occupation, Meaningful Activity in Care Homes / Nursing Homes, Meaningful Occupation, Meaningful Occupation Interventions, Mental Health and Wellbeing, Mental Health and Wellbeing in Adult Social Care, Mental Wellbeing, Mental Wellbeing and Older People, Mental Wellbeing of Older People in Care Homes, Mental Wellbeing of Older People in Care Homes (QS50), Mental Wellbeing of Older People in Care Homes: Support for Commissioning, Montessori Principles, National Institute for Health and Care Excellence (NICE), National Institute for Health Research (NIHR), National Institute for Health Research Signal, Need-Driven Dementia-Compromised Behavior (NDB) Model, Needs of Older People Living in Care Homes, NICE Quality Standard QS50, NIHR Signal, Norway, Nursing Homes, Occupational Therapy, Occupational Therapy in Care Homes, Occupational Therapy Programmes, Oxford Health NHS Foundation Trust, Patient Engagement, People with Dementia in Care Homes, People With Dementia in Long-Term Care, People With Dementia Living in Care Homes, People With Dementia Living in Nursing Homes, Person-Centred Activities for People With Dementia Living in Nursing Homes, Person-Centred Care Training for People With Dementia Living in Nursing Homes, Personal Identity, Personalised Social Interaction, Personally Tailored Activities for People With Dementia in Long-Term Care, PLoS Medicine, Preventing Isolation, Professor Martin Orrell, Recreational Activities, Recreational Stimulation, Reducing Agitation and Distress, Reducing Antipsychotic Drugs in Care Homes, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics, Reducing Violence and Aggression, Reminiscence Therapy, Residential Aged Care Facilities (RACFs), Residential Care, Residential Care Homes, Sawinery, Self-Determination Theory, Social Interaction, Systematic Reviews, Treatment Routes for Exploring Agitation (TREA) Framework, University College London, University of Freiburg, University of Hull, University of Nottingham, WHELD Intervention, WHELD Programme, Woodworking (Hobby), Woodworking for the Elderly | Leave a comment

One Hour of Social Interaction Per Week Improves Dementia Care (NIHR / NHS Choices / PLoS Medicine)

Posted on February 23, 2018 by Dementia and Elderly Care News

Summary NIHR-funded research indicates that a modest amount of social interaction improves quality of life for people with dementia living in care homes. Agitation and aggression were reduced by these cost-effective means, and the quality of life in people with … Continue reading →

Posted in Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, Mental Health, Models of Dementia Care, NHS Digital (Previously NHS Choices), NIHR, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Personalisation, Quick Insights, UK, Universal Interest | Tagged Abbey Pain Scale, Advancing Care: Research With Care Homes (NIHR), Agitation, Agitation and Aggression, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotics, Alzheimer's Society, Antipsychotic Prescribing in Care Homes, Antipsychotic Prescribing in Nursing Homes, Antipsychotics Limitation in Dementia, Bangor University, Bazian, Behavioural Alternatives to Antipsychotic Drugs, Behind the Headlines, Camberwell Assessment of Need for the Elderly, Care Homes, Centre for Age-Related Medicine (SESAM): Helse Stavanger University Hospital, Clinical Dementia Rating (CDR), Clinical Dementia Rating Scale, CMAI (Cohen Mansfield Agitation Inventory), Cohen-Mansfield Agitation Inventory (CMAI), Cohen-Mansfield Agitation Inventory (CMAI) Scores, Cornell Scale for Depression in Dementia (CSDD), Dementia Services Development Centre Wales: Bangor University, Dementia-Related Agitation, DEMQOL-Proxy, DEMQoL-Proxy: Dementia Quality of Life Proxy, Division of Psychiatry and Applied Psychology: University of Nottingham, Division of Psychiatry: University College London, Encouraging Independence and Social Interaction, Exeter University, Exeter University Medical School: Exeter University, Faculty of Health and Social Sciences: University of Hull, Helse Stavanger University Hospital (Norway), Improving Wellbeing and Health for People with Dementia (WHELD) Trial, Institute of Mental Health: University of Nottingham, Kings College London, London School of Economics, Managing Agitation, National Institute for Health Research (NIHR), National Institute for Health Research Signal, Neuroleptic Discontinuation, Neuropsychiatric Inventory-Nursing Home version (NPI-NH), NIHR Programme Grants for Applied Research (PGfAR) Programme, NIHR Signal, Norway, Nursing Homes, Oxford Health NHS Foundation Trust, People With Dementia Living in Care Homes, People With Dementia Living in Nursing Homes, Person-Centred Activities for People With Dementia Living in Nursing Homes, Person-Centred Care Training for People With Dementia Living in Nursing Homes, Personalised Social Interaction, PLoS Medicine, Professor Martin Orrell, Programme Grants for Applied Research (PGfAR) Programme (NIHR), Quality of Interactions Scale (QUIS), Reducing Agitation and Distress, Reducing Antipsychotic Drugs in Care Homes, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics, Reducing Violence and Aggression, Residential Care, Residential Care Homes, Social Interaction, University College London, University of Hull, University of Nottingham, WHELD Intervention, WHELD Programme, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Stop the Over-Medication of People With a Learning Disability or Autism (STOMP) Campaign (NHS England / Royal College of Psychiatrists / BPS)

Posted on July 16, 2017 by Dementia and Elderly Care News

Summary Professor Jane Cummings, Chief Nursing Officer for England, has written to raise awareness about the over-medication of people with learning disabilities or autism, on the first anniversary of the Stop the Over-Medication of People With a Learning Disability or Autism … Continue reading →

Dementia with Lewy Bodies: Updated DLB Consortium Diagnosis and Management Consensus Report (Neurology)

Posted on July 13, 2017 by Dementia and Elderly Care News

Summary The Dementia with Lewy Bodies (DLB) Consortium has published an updated set of recommendations on diagnosis and management of DLB. Clinical features and diagnostic biomarkers are covered, with guidance on their interpretation. Previously omitted aspects of Lewy-related pathology are … Continue reading →

Posted in Antipsychotics, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Quick Insights, UK | Tagged Abnormal Proteins (Alpha-Synuclein), Acting Out Dreams: Rapid Eye Movement (REM) Sleep Behaviour Disorder, Alpha-Synuclein Aggregation, Alpha-Synucleinopathies, Alternatives to Antipsychotics, Antipsychotics Limitation in Dementia, Antipsychotics: Neuroleptic Sensitivity, Assessment and Diagnosis, Australia, Autonomic System Dysfunction, Banner Sun Health Research Institute, Behavior and Mood Changes, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural and Psychological Symptoms of Dementia (BPSD), Biomarker Development, Biomarkers, Biomarkers Research Programmes, Blackouts, Brain and Mind Centre: University of Sydney, Brain Stimulation, Center for Neurodegenerative Disease Research: University of Pennsylvania, Centre for Age-Related Diseases: Stavanger University Hospital, Cognitive Decline (DLB vs. Alzheimer's), Cognitive Symptoms, Comparison of Cognitive Decline (DLB vs. AD), Deep Brain Stimulation for the Treatment of Dementia, Delusions, Dementia With Lewy Bodies (DLB), Dementia With Lewy Bodies (DLB) Consortium, Department of Laboratory Medicine and Pathology: Mayo Clinic, Department of Neurology: Mayo Clinic, Department of Neurology: Mayo Clinic (Rochester), Department of Neurology: University of Pennsylvania, Department of Neuroscience and Neuropathology Laboratory: Mayo Clinic, Department of Neuroscience Imaging and Clinical Sciences: University G. d'Annunzio of Chieti-Pescara, Department of Neuroscience: Mayo Clinic, Department of Psychiatry and Psychology: Mayo Clinic, Department of Veterans Affairs, Departments of Radiology and Neurology: University of Michigan, Diagnosis and Management of Dementia with Lewy Bodies, Diagnosis and Screening: Dementia with Lewy Bodies, Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-V), Differential Diagnosis, Dizziness, DLB, DLB Management, DLB: Dementia with Lewy Bodies, Drooling, DSM-5, Early Diagnosis, Early Diagnosis of Lewy Body Dementia (LBD), Early Diagnosis of Parkinson’s Disease and DLB, Fainting, Florida Atlantic University, Fluctuating Cognition, Fluctuations, Fourth Consensus Report of DLB Consortium, Hallucinations, Handwriting, ICube Laboratory, Institute for Healthy Aging and Lifespan Studies (I-HeAL): Florida Atlantic University, Institute of Neuroscience: Newcastle University, Institute of Psychiatry Psychology and Neuroscience: King’s College London, Italy, α-Synuclein, α-Synuclein Aggregation, α-Synuclein Misfolds, Kings College London, Lewy Body Degeneration, Lewy Body Dementia, Lewy Body Dementia (LBD), Lewy Body Dementia Symptoms Checklists, Lewy Body Society, Medical School: University of Exeter; University of Exeter, Misdiagnosis, Mood Changes, Neurodegenerative Disease Research, Neurodegenerative Diseases, Neurodegenerative Disorders, Neuroleptic Sensitivity, Neurology (Journal), Norway, Parkinson's Disease and Mental Illness Research Education and Clinical Centers (PADRECC and MIRECC): Philadelphia Veterans Affairs Medical Center, Parkinson’s-Like Symptoms, Perelman School of Medicine: University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, Postural Instability, Preclinical Biomarkers and Dementia, Prion-Like Mechanisms, Repeated Falls, Severe Neuroleptic Sensitivity, Severe Sensitivity to Antipsychotic Agents, Shuffling Walk, Sleep Disorders Center: Mayo Clinic, Stavanger University Hospital, Stavanger University Hospital; Norway, Synucleinopathies, Synucleinopathy, Synucleinopathy Progression, Transient Loss of Consciousness, Underlying Mechanisms of DLB Pathogenesis, United States, University G. d'Annunzio of Chieti-Pescara, University Hospital of Strasbourg, University of Michigan, University of Pennsylvania, University of Strasbourg, University of Sydney | Leave a comment

Psychological Interventions For Dementia: Putting the Person at the Centre of Care (BPS)

Posted on November 20, 2016 by Dementia and Elderly Care News

Summary The British Psychological Society’s Dementia Advisory Group has produced a report on the psychological aspects of dementia care; particularly covering the roles of psychologists in providing practical support. Recommendations are presented concerning: Prevention / risk-reduction. Assessment. Planning of care. … Continue reading →

Posted in Antipsychotics, Commissioning, Delirium, Depression, Diagnosis, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Northern Ireland, Person-Centred Care, Personalisation, Quick Insights, Scotland, Standards, Statistics, UK, Universal Interest, Wales | Tagged Alternatives to Antipsychotic Medication, Alternatives to Antipsychotics, Assessment and Diagnosis, Behavioural Alternatives to Antipsychotic Drugs, Behavioural and Psychological Symptoms of Dementia (BPSD), BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society (BPS), British Psychological Society Dementia Advisory Group, British Psychological Society’s Dementia Advisory Group, Care Planning, Challenging Behaviour in Dementia, Dementia Advisory Group (British Psychological Society), Dementia as a Problematic Experience, Dementia Diagnosis, Dementia Research, Dementia Risk Prevention, Dementia Risk Reduction and Prevention, Dementia Training and Research, Elderly Mental Health, Families and Carers, Families and Carers as Partners in Dementia Care, Healthy Lifestyles, Involvement of Families and Carers, Join Dementia Research, Lifestyle Risk Factors, Management of Challenging Behaviour, Participation in Research, Prevention, Psychological Approaches in Managing Psychological and Behavioural Distress, Psychological Dimensions of Dementia, Psychological Interventions For Dementia, Psychological Problems of Older People, Psychological Symptoms of Dementia (BPSD), Public Involvement in Research, Risk Reduction (Formerly Termed Prevention by WDC), Treatment and Support (Psychological Interventions) | Leave a comment

Introducing the Journal of Geriatric Care and Research (JGCR)

Posted on July 3, 2016 by Dementia and Elderly Care News

Summary The Journal of Geriatric Care and Research (ISSN 2397-5628) is a recently launched, locally edited, multi-disciplinary peer-reviewed international journal, which covers topics of relevance to the care of the elderly. Concerning Guidelines on the Use of Antipsychotics for Agitation … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Guidelines, International, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, Person-Centred Care, Pharmacological Treatments, Quick Insights, Wales, Wolverhampton | Tagged Academia.edu, Adverse Drug Reactions (ADRs), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Agitation, Agitation and Aggression, Alternatives to Antipsychotics, Alzheimer’s Disease-Related Agitation, American Journal of Psychiatry, American Psychiatric Association (APA), American Psychiatric Association: Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia (2016), Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Neuroleptic Sensitivity, APA Practice Guidelines, Aripiprazole, Atypical Antipsychotics, Avoidable Harm, Avoidable Hospital Mortality, Avoidable Mortality, Behavioural and Psychological Symptoms of Dementia (BPSD), Benefits and Risks of Antipsychotic Treatment, Betsi Cadwaladr University Health Board, Black Country, Black Country Partnership NHS Foundation Trust, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Indian Psychiatric Association (BIPA), Community and Mental Health Trusts, Dr Sarmishtha Bhattacharyya: Consultant in Old Age Psychiatry at Wrexham Maelor Hospital, Faculty of Health and Social Care: University of Chester, Geriatric Care and Research Organisation (GeriCaRe), Haloperidol, Improving Prescribing Practice, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Journal of Geriatric Care and Research (JGCR), Learning Disabilities, Medication Reviews, Mental Health Trusts, North Wales, Olanzapine, Over-Medication, Over-Medication for People With Learning Disabilities, Over-Prescribing, Overprescribing, People With Learning Disabilities, Personalised Care Versus Guideline-Based Care, Personalised Medicine Versus Guideline-Based Medicine, Potential Harms of Antipsychotic Use, Potentially Inappropriate Prescribing, Prescribing Anti-Psychotic Drugs to People with Dementia, Prescribing of Antipsychotic Drugs For People With Dementia, Prescribing of Antipsychotic Drugs For People With Learning Disabilities, Psychosis in Patients With Dementia, Quetiapine, Reducing Agitation and Distress, Reducing Antipsychotic Prescriptions in Dementia, Reducing Avoidable Premature Mortality, Reducing Inappropriate Use of Antipsychotics, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Safe and Compassionate Care, United States, University of Chester, USA, Violence and Aggression, West Midlands, Wrexham, Wrexham Maelor Hospital, Ziprasidone | Leave a comment

Over-Medication of People With Learning Disabilities? (BBC News / BMJ / PHE)

Posted on September 2, 2015 by Dementia and Elderly Care News

Summary Analysis of GP data over a decade has revealed that over one quarter of 33,000 adults with learning disabilities (and / or some forms of dementia) may have been prescribed antipsychotics unnecessarily, usually as a result of challenging behaviour. … Continue reading →

Posted in Antipsychotics, BBC News, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, Management of Condition, Mental Health, National, NHS, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Public Health England, Quick Insights, Standards, Statistics, UK, Universal Interest | Tagged Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotics, Antidepressants, Antipsychotics, Anxiolytics and Hypnotics (Including Benzodiazepines), Baily Thomas Charitable Fund, BBC Health News, Behavioural Alternatives to Antipsychotic Drugs, BMJ, British Medical Journal (BMJ), Challenging Behaviour, Chemical Restraint, Division of Psychiatry: University College London, Drugs for Attention-Deficit / Hyperactivity Disorder, Improving Prescribing Practice, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, Learning Disabilities, Mood Stabilisers, National Institute for Health Research (NIHR), Over-Medication, Over-Medication for People With Learning Disabilities, Over-Prescribing, Overprescribing, People With Learning Disabilities, Potentially Inappropriate Prescribing, Prescribing of Antipsychotic Drugs For People With Dementia, Prescribing of Antipsychotic Drugs For People With Learning Disabilities, Prescription of Psychotropic Drugs, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics, Research Department of Primary Care and Population Health: University College London (Royal Free Campus), The Health Improvement Network (THIN), University College London | Leave a comment

Use of Quality Standards to Improve Practice in Care Homes for Older People (NICE)

Posted on January 13, 2015 by Dementia and Elderly Care News

Summary The National Institute for Health and Care Excellence (NICE) has published a brief resource explaining how NICE quality standards fit together and relate to improvement initiatives relating to care homes. It explains how to use NICE quality standards to … Continue reading →

Posted in Antipsychotics, Commissioning, Community Care, CQC: Care Quality Commission, End of Life Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Integrated Care, Local Interest, Management of Condition, Mental Health, Models of Dementia Care, National, NICE Guidelines, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Personalisation, Practical Advice, Quick Insights, Standards, UK, Universal Interest | Tagged Access to Care, Access to Healthcare Services, Access to Primary Care, Access to Services, Activity in Care Homes, Adult Mental Health Services, Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotics, Antipsychotic Prescribing in Care Homes, Best Practice in Care Homes, Care Homes, Care Homes Wellbeing, Care Homes: Last Year of Life, Care Quality Commission (CQC), Care Quality Commission’s Inspection Framework, Caring (CQC Inspection Question), Caring Indicators (CQC), Choice and Control Over Decisions, Community Mental Health, Coordinated Care, CQC Inspection Framework Questions and Related NICE Quality Standards, CQC Inspection Questions (Safe Effective Caring Responsive Well-Led), Delirium, Dementia (QS1), Dementia Care in Care Homes, Dementia-Friendly Care Homes, Depression in Adults (QS8), Diversity, Diversity Equality and Language, Effective (CQC Inspection Question), Elderly Mental Health, Emotional and Psychological Wellbeing, End of Life Care for Adults (QS13), End of Life Care in Care Homes, Equality, Health and Wellbeing, Holistic Care, Identity, Improving Access to Psychological Therapies (IAPT) Programme, Independence, Independent Advocacy, Infection Prevention and Control, Language, Low Self-Esteem, Maintaining Identity, Maintaining Independence, Managers of Care Homes for Older People, Managing Medicines in Care Homes, Managing Ongoing Physical and Mental Health Conditions, Meaningful Activity, Meaningful Activity and Occupation, Mental Health and Wellbeing, Mental Health Services, Mental Wellbeing, Mental Wellbeing and Older People, Mental Wellbeing of Older People in Care Homes, Mental Wellbeing of Older People in Care Homes (QS50), Mental Wellbeing of Older People in Care Homes: Support for Commissioning, National Institute for Health and Care Excellence (NICE), Needs of Older People Living in Care Homes, NICE Collaborating Centre for Social Care (NCCSC), NICE Quality Standard 1 (QS1), NICE Quality Standard QS50, NICE Quality Standards, NICE Quality Standards Mapped to Related CQC Inspection Framework Questions, NICE Quality Standards on Improving Practice in Care Homes for Older People, NICE Resources Tailored for Managers of Care Homes for Older People, Patient Experience in Adult NHS Services (QS15), Patient Identity, People with Dementia in Care Homes, Personal Identity, Physical Problems, Physical Wellbeing, Quality Statement 1: Participation in Meaningful Activity, Quality Statement 2: Personal Identity, Quality Statement 3: Recognition of Mental Health Conditions, Quality Statement 4: Recognition of Sensory Impairment, Quality Statement 5: Recognition of Physical Problems, Quality Statement 6: Access to Healthcare Services, Recognition of Mental Health Conditions, Recognition of Physical Problems, Recognition of Sensory Impairment, Residential Care Homes, Responsive (CQC Inspection Question), Safe (CQC Inspection Question), Sense of Identity, Sensory Impairment, Sensory Loss, Service User Experience in Adult Mental Health (QS14), Supporting Older People in Care Homes At Night, Supporting People to Live Well With Dementia (QS30), Supporting People to Live Well with Dementia: QS30 (NICE), Visual Impairment, Well-Led (CQC Inspection Question), Wellbeing, Wellbeing and an Ageing Population, Wellbeing in Later Life, Workforce Competencies, Workforce Development, Workforce Planning, Workforce Training | Leave a comment

Reducing Antipsychotic Prescribing for BPSD (BMJ / JAMA / JAMA Psychiatry / BJCP)

Posted on November 6, 2014 by Dementia and Elderly Care News

Summary This BMJ “Change page” article discusses the potential harms associated with use of antipsychotics in people with dementia, and covers guidelines recommending restrictions in their use. Risperidone is the antipsychotic recommended for use in the treatment of aggression associated … Continue reading →

Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Mental Health, Models of Dementia Care, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, Statistics, UK | Tagged Adverse Drug Reactions (ADRs), Adverse Drug Reactions (ADRs): Type A (Potentially Avoidable and Associated With Commonly Prescribed Medications), Adverse Drug Reactions in the Elderly, Adverse Effects, Aggression, Aggressive Behaviour, Alternatives to Antipsychotics, Antidepressants, Antihypertensives, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics Limitation in Dementia, Antipsychotics Side Effects, Antipsychotics-Related Mortality Risks, Antipsychotics: Absolute Mortality Risk Increase, Antipsychotics: Neuroleptic Sensitivity, Antipsychotics: Number Needed to Harm (NNH), Atypical Antipsychotics, Behavioural and Psychological Symptoms of Dementia (BPSD), Benzodiazepines, BMJ, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brief Psychosocial Treatment, British Journal of Clinical Pharmacology, British Medical Journal (BMJ), Campbell Institute (CAMH): University of Toronto, Cardiff University, Center for Clinical Management Research: Veterans Affairs Ann Arbor Healthcare System (Michigan), Center for Statistical Consultation and Research: University of Michigan, CitAD Research Group, Citalopram for Agitation in Alzheimer's Disease: CitAD Trial, Clinical Biotechnology Research Institute: Roper St Francis Healthcare (Charleston: South Carolina), College of Physicians and Surgeons of Columbia University, DART-AD: Dementia Antipsychotic Withdrawal Trial (DART-AD), Dementia Antipsychotic Withdrawal Trial (DART-AD), Department of Psychiatry: University of Michigan, Department of Psychiatry: University of Southern California, Discontinuation of Antipsychotics, Effect of Citalopram on Agitation in Alzheimer Disease (CitAD Randomized Clinical Trial), Falls Prevention, Hotchkiss Brain Institute: University of Calgary, Inappropriate Prescribing, Inappropriate Use of Antipsychotics in Dementia, International Conference on Harmonization, JAMA, JAMA Psychiatry, Johns Hopkins Bayview and Johns Hopkins School of Medicine, Johns Hopkins Bloomberg School of Public Health: Baltimore, Kings College London, Medication Reviews, National Institute for Health Research (NIHR): Mental Health Biomedical Research Centre and Dementia Unit, NEST Approach, Neuroleptic Discontinuation, Neuroleptics, New York State Psychiatric Institute, Patients’ Needs and the Environment Stimulation and Techniques (NEST), Perelman School of Medicine: University of Pennsylvania, Personalised Social Interaction, Pharmacokinetics, Polypharmacy, Potential Harms of Antipsychotic Use, Prescribing Anti-Psychotic Drugs to People with Dementia, Reducing Agitation and Distress, Reducing Antipsychotic Medication in Care Homes, Reducing Antipsychotic Prescriptions in Dementia, Reducing Inappropriate Use of Antipsychotics in Dementia, Reducing Violence and Aggression, Risperidone, Seattle Protocols, Simulated Presence Therapy, South London and Maudsley NHS Foundation Trust, Stanford University School of Medicine, United States, University Hospital Llandough (Cardiff), University of Calgary, University of Manchester, University of Michigan, University of Pennsylvania, University of Rochester School of Medicine and Dentistry, University of Southern California, University of Southern California Keck School of Medicine, University of Toronto, Violence and Aggression, Wolfson Centre for Age-Related Diseases: King’s College London | Leave a comment

Tag Archives: Alternatives to Antipsychotics

Recent Posts

Archives

Categories

Google Translate (100+ Languages)

Recommended Sites